Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoFAR6: Viaskin Peanut for Peanut Allergy
NCT01904604Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2013
- Primary completion
- Aug 2015
- Modality
- Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of peanut protein in peanut allergy, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2013; status: completed.
02
Drugs
peanut protein
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT01904604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01904604.